Nurix Therapeutics, Inc. (NRIX)

Nurix Therapeutics Revenue

Nurix Therapeutics had revenue of $12.59M in the quarter ending August 31, 2024, a decrease of -31.84%. This brings the company's revenue in the last twelve months to $56.42M, down -17.76% year-over-year. In the fiscal year ending November 30, 2023, Nurix Therapeutics had annual revenue of $76.99M with 99.31% growth.

• Revenue (ttm): $56.42M
• Revenue Growth: -17.76%
• P/S Ratio: 21.51
• Revenue / Employee: $198,676
• Employees: 284
• Market Cap: 1.40B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Nov 30, 2023	76.99M	38.36M	99.31%
Nov 30, 2022	38.63M	8.88M	29.84%
Nov 30, 2021	29.75M	11.93M	66.95%
Nov 30, 2020	17.82M	-13.30M	-42.73%
Nov 30, 2019	31.12M	-6.33M	-16.91%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.